The Global Chromatography Solvents Market is expected to reach USD 3,536.8 billion by 2024 from USD 1,708.0 billion in 2016, at a CAGR of 9.5% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Polar solvents market has the largest market segment in chromatography solvents market.

Access Full Report: https://www.databridgemarketresearch.com/reports/global-chromatography-solvents-market

Global Chromatography Solvents MarketThe global chromatography solvents market is highly concentrated to a big player and rest to local players who cater to domestic markets only. In 2016, the global chromatography solvents market is dominated by EMD Millipore, having a market share of 43.1%, owing to the acquisition of Sigma Aldrich completed in 2015. EMD Millipore, dominated the chromatography solvents market accounting for the highest market share in 2016, followed by Avantor Performance Materials and Thermo Fisher Scientific, Inc. Other players in this market include Avantor Performance Materials, Tedia Company Inc., Regis Technologies Inc., Thermo Fisher Scientific, Inc., VWR International, Qualikems Fine Chem Pvt. Ltd., and Waters Corporation among other local players.

Thermo Fisher Scientific Inc.: 

Founded in 2006 and headquartered at Massachusetts in USA. The company operates through four business segments, namely, Laboratory Products and Services, Life Sciences and Solutions, Analytical Instruments and Specialty Diagnostic. Life Sciences solutions provides an extensive portfolio of instruments, reagents and consumables used in medical research and biological, discovery and production of vaccines and new drugs  as well as diagnosis of diseases. Analytical Instruments segment provides a broad offering of consumables, instruments, software and services that are used for a range of applications in the laboratory, on the production line and in the field. Specialty diagnostics segment provides a wide range of diagnostic test kits, reagents, instruments and associated products used to increase the speed and accuracy of diagnoses.


Founded in 1852 and headquartered at Pennsylvania in U.S.A; VWR International is engaged in pharmaceutical, biotechnology, industrial, education, government and healthcare industries. The company operates through three business segments, namely, Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women’s health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedics, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care.


Founded in 1886 and headquartered at Massachusetts, U.S.A.; Waters Corporation is engaged in developing analytical science solutions to support customer discoveries, performance, operations and regulatory compliance. The company operates through two business segments, namely, Water divison and TA instruments. The water division segment of the company creates business advantages for laboratory-dependent organizations by delivering practical and scientific innovation to enable significant advancement in healthcare delivery, food safety, water quality and environmental management. The TA instruments segment develops and supplies thermal analysis and rheometry instruments that are used in predicting the suitability of fine chemicals and polymers used in various industrial, consumer goods and healthcare products.